tradingkey.logo


tradingkey.logo


STRATA Skin Sciences Inc

SSKN
0.190USD
0.0000.00%
取匕時間 ET15分遅れの株䟡
11.51K時䟡総額
損倱額盎近12ヶ月PER


STRATA Skin Sciences Inc

0.190
0.0000.00%

詳现情報 STRATA Skin Sciences Inc 䌁業名

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

STRATA Skin Sciences Incの䌁業情報


䌁業コヌドSSKN
䌚瀟名Strata Skin Sciences Inc
䞊堎日Oct 28, 2005
最高経営責任者「CEO」Rafaeli (Dolev)
埓業員数106
蚌刞皮類Ordinary Share
決算期末Oct 28
本瀟所圚地5 Walnut Grove Drive, Suite 140
郜垂HORSHAM
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号19044
電話番号12156193200
りェブサむトhttps://www.strataskinsciences.com/
䌁業コヌドSSKN
䞊堎日Oct 28, 2005
最高経営責任者「CEO」Rafaeli (Dolev)

STRATA Skin Sciences Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
20.00K
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
20.00K
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
7.50K
--
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
2.00K
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
20.00K
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
20.00K
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
7.50K
--
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
2.00K
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States (Country)
5.22M
75.31%
Other foreign
939.00K
13.55%
Foreign
470.00K
6.78%
Middle East
172.00K
2.48%
China
130.00K
1.88%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: 17 hours ago
曎新時刻: 17 hours ago
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Rafaeli (Dolev)
2.43%
他の
50.89%
株䞻統蚈
株䞻統蚈
比率
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Rafaeli (Dolev)
2.43%
他の
50.89%
皮類
株䞻統蚈
比率
Private Equity
24.49%
Investment Advisor/Hedge Fund
9.61%
Hedge Fund
8.27%
Corporation
6.21%
Investment Advisor
0.64%
Individual Investor
0.18%
他の
50.60%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
39
2.56M
43.55%
-107.46K
2025Q3
40
2.60M
49.33%
-171.52K
2025Q2
42
2.84M
68.01%
+22.22K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
2023Q3
53
2.57M
73.29%
-212.86K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Accelmed Growth Partners Management Ltd
1.44M
24.49%
--
--
Sep 04, 2025
22NW, LP
537.00K
9.12%
--
--
Sep 30, 2025
Nantahala Capital Management, LLC
403.92K
6.86%
--
--
Sep 30, 2025
Lincoln Alternative Strategies LLC
365.85K
6.21%
+365.85K
--
Sep 03, 2025
Renaissance Technologies LLC
101.53K
1.72%
+3.50K
+3.57%
Sep 30, 2025
Geode Capital Management, L.L.C.
18.14K
0.31%
-56.00
-0.31%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
日付
配圓萜ち日
皮類
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
KeyAI
î™